EKTAY.US Elekta AB ADR

Healthcare Health Care Equipment & Supplies USA Stocks
6.46 USD
Close of Nov 14, 2026
4.24 6.59
Market cap
USD 2.37B
P/E
-
P/B
3.04x
ROE
14.0%
Dividend yield
4.08%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is EKTAY.US undervalued?

Graham number

The Graham number of Elekta AB ADR cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Elekta AB ADR fundamental analysis

No fundamental analysis for Elekta AB ADR yet.

Elekta AB ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Elekta AB ADR

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-compl…

Full company profile